Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis

Arthritis Research and Therapy

Volumn 14, Issue 6, 2012, Pages

  Toonen, Erik J M ^a   Barrera, Pilar ^a   Fransen, Jaap ^a   de Brouwer, Arjan P M ^a   Eijsbouts, Agnes M ^b   Miossec, Pierre ^c   Marotte, Hubert ^c   Scheffer, Hans ^a   van Riel, Piet L C M ^a   Franke, Barbara ^a   Coenen, Marieke J H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b St Maartenskliniek ^*  (Netherlands)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD ANALYSIS; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; DNA POLYMORPHISM; GENE EXPRESSION; GENETIC ANALYSIS; GENOTYPE; HUMAN; JOINT INJURY; JOINT RADIOGRAPHY; META ANALYSIS; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; PROMOTER REGION; REGRESSION ANALYSIS; RHEUMATOID ARTHRITIS; RISK FACTOR; RNA ISOLATION; SEX DIFFERENCE; ADULT; AGED; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; JOINT DISEASES; MALE; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; TIME;

ADULT; AGED; ARTHRITIS, RHEUMATOID; COHORT STUDIES; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; JOINT DISEASES; LINEAR MODELS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84870511681     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4110     Document Type: Article

References (31)

1. Mosaad YM, Abdelsalam A, El-Bassiony SR. Association of tumour necrosis factor-alpha -308 G/A promoter polymorphism with susceptibility and disease profile of rheumatoid arthritis. Int J Immunogenet 2011, 38:427-433. 10.1111/j.1744-313X.2011.01028.x, 21806780.
2. Brinkman BM, Huizinga TW, Kurban SS, van der Velde, Schreuder GM, Hazes JM, Breedveld FC, Verweij CL. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease?. Br J Rheumatol 1997, 36:516-521. 10.1093/rheumatology/36.5.516, 9189051.
3. Hussein YM, Mohamed RH, Pasha HF, El-Shahawy EE, Alzahrani SS. Association of tumor necrosis factor alpha and its receptor polymorphisms with rheumatoid arthritis in female patients. Cell Immunol 2011, 271:192-196. 10.1016/j.cellimm.2011.06.023, 21777909.
4. Reneses S, Gonzalez-Escribano MF, Fernandez-Suarez A, Pestana L, Davila B, Wichmann I, Garcia A. The value of HLA-DRB1 shared epitope, -308 tumor necrosis factor-alpha gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis. J Rheumatol 2009, 36:1143-1149. 10.3899/jrheum.081075, 19411391.
5. Ates O, Hatemi G, Hamuryudan V, Topal-Sarikaya A. Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients. Clin Rheumatol 2008, 27:1243-1248. 10.1007/s10067-008-0893-1, 18427872.
6. Nemec P, Pavkova-Goldbergova M, Stouracova M, Vasku A, Soucek M, Gatterova J. Polymorphism in the tumor necrosis factor-alpha gene promoter is associated with severity of rheumatoid arthritis in the Czech population. Clin Rheumatol 2008, 27:59-65. 10.1007/s10067-008-0924-y, 17562093.
7. Rezaieyazdi Z, Afshari JT, Sandooghi M, Mohajer F. Tumour necrosis factor a -308 promoter polymorphism in patients with rheumatoid arthritis. Rheumatol Int 2007, 28:189-191. 10.1007/s00296-007-0444-0, 17763852.
8. Kazkaz L, Marotte H, Hamwi M, Angelique CM, Roy P, Mougin B, Miossec P. Rheumatoid arthritis and genetic markers in Syrian and French populations: different effect of the shared epitope. Ann Rheum Dis 2007, 66:195-201. 1798494, 17068065.
9. Khanna D, Wu H, Park G, Gersuk V, Gold RH, Nepom GT, Wong WK, Sharp JT, Reed EF, Paulus HE, Tsao BP. Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort. Arthritis Rheum 2006, 54:1105-1116. 10.1002/art.21750, 16572445.
10. Pawlik A, Florczak M, Ostanek L, Brzosko M, Brzosko I, Szklarz BG. TNF-alpha -308 promoter polymorphism in patients with rheumatoid arthritis. Scand J Rheumatol 2005, 34:22-26.
11. Rojas-Villarraga A, Diaz FJ, Calvo-Paramo E, Salazar JC, Iglesias-Gamarra A, Mantilla RD, Anaya JM. Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis. J Autoimmun 2009, 32:64-69. 10.1016/j.jaut.2008.11.004, 19117726.
12. Lacki JK, Moser R, Korczowska I, Mackiewicz S, Muller W. TNF-alpha gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis. Rheumatol Int 2000, 19:137-140. 10.1007/s002960050117, 10836523.
13. Fonseca JE, Cavaleiro J, Teles J, Sousa E, Andreozzi VL, Antunes M, maral-Turkman MA, Canhao H, Mourao AF, Lopes J, Caetano-Lopes J, Weinmann P, Sobral M, Nero P, Saavedra MJ, Malcata A, Cruz M, Melo R, Braña A, Miranda L, Patto JV, Barcelos A, da Silva JC, Santos LM, Figueiredo G, Rodrigues M, Jesus H, Quintal A, Carvalho T, da Silva JA, et al. Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter. Arthritis Res Ther 2007, 9:R37. 10.1186/ar2173, 1906815, 17408492.
14. Wilson AG, de VN, van de Putte LB, Duff GW. A tumour necrosis factor alpha polymorphism is not associated with rheumatoid arthritis. Ann Rheum Dis 1995, 54:601-603. 10.1136/ard.54.7.601, 1009943, 7668906.
15. Bouma G, Crusius JB, Oudkerk PM, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Pena AS. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 1996, 43:456-463. 10.1046/j.1365-3083.1996.d01-65.x, 8668926.
16. Hajeer AH, Hutchinson IV. Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol 2001, 62:1191-1199. 10.1016/S0198-8859(01)00322-6, 11704281.
17. Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 1999, 66:562-566.
18. Kroeger KM, Abraham LJ. Identification of an AP-2 element in the -323 to -285 region of the TNF-alpha gene. Biochem Mol Biol Int 1996, 40:43-51.
19. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997, 34:391-399. 10.1016/S0161-5890(97)00052-7, 9293772.
20. Braun N, Michel U, Ernst BP, Metzner R, Bitsch A, Weber F, Rieckmann P. Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production. Neurosci Lett 1996, 215:75-78.
21. Oregon-Romero E, Vazquez-Del MM, Ruiz-Quezada SL, Navarro-Hernandez RE, Rangel-Villalobos H, Martinez-Bonilla G, Bernard-Medina AG, rmendariz-Borunda J, Garcia-Banuelos J, Munoz-Valle JF. Tumor necrosis factor alpha-308 and -238 polymorphisms in rheumatoid arthritis. Association with messenger RNA expression and sTNF-alpha. J Investig Med 2008, 56:937-943.
22. Munoz-Valle JF, Oregon-Romero E, Rangel-Villalobos H, Martinez-Bonilla GE, Castaneda-Saucedo E, Salgado-Goytia L, Leyva-Vazquez MA, Illades-Aguiar B, arcon-Romero LD, Espinoza-Rojo M, Parra-Rojas I. High expression of TNF alpha is associated with -308 and -238 TNF alpha polymorphisms in knee osteoarthritis. Clin Exp Med 2012,
23. Helmig S, Aliahmadi N, Stephan P, Dohrel J, Schneider J. TNF-alpha -308 genotypes are associated with TNF-alpha and TGF-beta(1) mRNA expression in blood leucocytes of humans. Cytokine 2011, 53:306-310. 10.1016/j.cyto.2010.11.018, 21169032.
24. Knight JC, Keating BJ, Rockett KA, Kwiatkowski DP. In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet 2003, 33:469-475. 10.1038/ng1124, 12627232.
25. Mekinian A, Tamouza R, Pavy S, Gestermann N, Ittah M, Mariette X, Miceli-Richard C. Functional study of TNF-alpha promoter polymorphisms: literature review and meta-analysis. Eur Cytokine Netw 2011, 22:88-102.
26. Welsing PM, van Riel PL. The Nijmegen inception cohort of early rheumatoid arthritis. J Rheumatol Suppl 2004, 69:14-21.
27. Rau R, Wassenberg S, Herborn G, Stucki G, Gebler A. A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol 1998, 25:2094-2107.
28. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215. 10.1093/nar/16.3.1215, 334765, 3344216.
29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
30. van den Berg WB, van Riel PL. Uncoupling of inflammation and destruction in rheumatoid arthritis: myth or reality?. Arthritis Rheum 2005, 52:995-999. 10.1002/art.20981, 15818666.
31. Jawaheer D, Li W, Graham RR, Chen W, Damle A, Xiao X, Monteiro J, Khalili H, Lee A, Lundsten R, Begovich A, Bugawan T, Erlich H, Elder JT, Criswell LA, Seldin MF, Amos CI, Behrens TW, Gregersen PK. Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet 2002, 71:585-594. 10.1086/342407, 449696, 12181776.